warning letter

FDA Warning: Bausch & Lomb Receives Letter on Product Issues

por

FDA Warning: Bausch & Lomb Receives Letter on Product Issues The U.S. Food and Drug Administration issued a formal warning letter to eye‑care giant Bausch & Lomb on September 4, 2026, flagging product‑related compliance concerns. The notice, reported by TradingView, underscores the agency’s ongoing vigilance over manufacturing and labeling practices that affect consumer safety. Understanding the … Leia mais

FDA Issues GMP Warning to Bausch and Lomb, Indian API Maker

por

FDA Issues GMP Warning to Bausch and Lomb, Indian API Maker The U.S. Food and Drug Administration has issued a formal warning to eye‑care giant Bausch & Lomb and an Indian active‑pharmaceutical‑ingredient (API) supplier for alleged violations of Good Manufacturing Practice (GMP). The notice, released in September 2026, details specific deficiencies that could affect product safety and efficacy. … Leia mais